prednisolone has been researched along with Bowel Diseases, Inflammatory in 77 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "While high-dose prednisolone treatment led to an increased anastomotic leakage rate in mice under colitis, low-dose prednisolone treatment limited preoperative disease activity and did not influence the leakage rate." | 8.31 | Perioperative Low-Dose Prednisolone Treatment Has Beneficial Effects on Postoperative Recovery and Anastomotic Healing in a Murine Colitis Model. ( Bauer, J; Buck, A; Clees, Z; Friess, H; Kasajima, A; Neumann, PA; Oertel, R; Reischl, S; Weber, MC; Wilhelm, D, 2023) |
| " Two young adult women are described in whom headache and papilloedema in association with raised intracranial pressure occurred during prednisolone treatment for inflammatory bowel disease." | 7.69 | Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease. ( Cooper, BT; Newton, M, 1994) |
| " After 25 days in the hospital, treatment with high dosage of methylprednisolone was started for presumed ulcerative colitis." | 5.28 | Fatal cytomegalovirus (CMV) colitis in a patient receiving low dose prednisolone therapy. ( Aukrust, P; Bjørneklett, A; Farstad, IN; Holter, E; Kremer, D; Moum, B, 1991) |
| "While high-dose prednisolone treatment led to an increased anastomotic leakage rate in mice under colitis, low-dose prednisolone treatment limited preoperative disease activity and did not influence the leakage rate." | 4.31 | Perioperative Low-Dose Prednisolone Treatment Has Beneficial Effects on Postoperative Recovery and Anastomotic Healing in a Murine Colitis Model. ( Bauer, J; Buck, A; Clees, Z; Friess, H; Kasajima, A; Neumann, PA; Oertel, R; Reischl, S; Weber, MC; Wilhelm, D, 2023) |
| " The fruit extract (50, 100 and 200mg/kg) treated enterocolitis rats significantly retain their body weight, organ weight, stool consistency, macroscopic score, histology, haematological parameters, antioxidative enzyme levels and also reduce the serum marker levels and myeloperoxidase (MPO) activity compared to prednisolone (2mg/kg) and sulfasalazine (50mg/kg) drugs." | 3.85 | Study of intestinal anti-inflammatory activity of Phoenix loureiroi Kunth (Arecaceae) fruit. ( Murugan, R; Parimelazhagan, T; Saravanan, S, 2017) |
| "Surface-deacetylated chitin nanofibers (SDACNFs) reinforced with a sulfobutyl ether β-cyclodextrin (SBE-β-CD) (NFs-CDs) gel were developed to obtain a controlled release carrier of prednisolone (PD) for the treatment of colitis." | 3.85 | Surface-deacetylated chitin nanofibers reinforced with a sulfobutyl ether β-cyclodextrin gel loaded with prednisolone as potential therapy for inflammatory bowel disease. ( Anraku, M; Hirayama, F; Ifuku, S; Iohara, D; Ishiguro, T; Nagae, T; Okazaki, S; Otagiri, M; Tabuchi, R; Takeshita, K; Uekama, K, 2017) |
| " Subsequently, its protective effect in indomethacin and iodoacetamide induced colitis in rats (45, 90, 180, 270 mg/kg) and acetic acid induced colitis in mice (65, 130, 250, 500 mg/kg) was assessed." | 3.77 | Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice. ( Jagtap, AG; Niphadkar, PV; Phadke, AS, 2011) |
| "The time course of a rocuronium-induced neuromuscular blockade (0." | 3.75 | Attenuation of a rocuronium-induced neuromuscular block in patients receiving prednisolone. ( Diefenbach, C; Mencke, T; Molter, GP; Soltész, S; Stunz, M; Ziegeler, S, 2009) |
| " Two young adult women are described in whom headache and papilloedema in association with raised intracranial pressure occurred during prednisolone treatment for inflammatory bowel disease." | 3.69 | Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease. ( Cooper, BT; Newton, M, 1994) |
| "Diarrhea is a common clinical feature of inflammatory bowel diseases and may be accompanied by abdominal pain, urgency, and fecal incontinence." | 2.48 | Diarrhea in chronic inflammatory bowel diseases. ( Wenzl, HH, 2012) |
| "Since IBD and especially Crohn's disease can effect the whole body, detailed analysis of inflammatory organ involvement is necessary before therapy." | 2.42 | [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy]. ( Göke, B; Ochsenkühn, T; Sackmann, M, 2003) |
| "The main standards of Crohn's disease therapy are presented on the bases of the small bowel Crohn's disease." | 2.41 | [Conservative therapy of inflammatory bowel diseases]. ( Nagy, F, 2002) |
| "The role of salicylates in Crohn's disease is limited to the mild activity phase; further data are required to clarify its role in maintenance on remission." | 2.41 | New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. ( Campieri, M, 2002) |
| "Aseptic abscesses associated with ulcerative colitis are difficult to differentiate from infectious abscesses." | 1.91 | Multiple ulcerative colitis-associated aseptic abscesses successfully treated with infliximab: a case report. ( Fujii, K; Fujimoto, A; Hojo, A; Ikegami, R; Matsuda, T; Nogami, A; Ogawa, Y; Toba, T; Watanabe, N, 2023) |
| "A 56-year-old Japanese man with ulcerative colitis and a history of Sweet's syndrome who was taking prednisolone and azathioprine presented with a moderate exacerbation of ulcerative colitis, abdominal pain, diarrhea, and bloody stools along with cytomegalovirus infection." | 1.91 | Ulcerative colitis successfully treated with vedolizumab in the presence of comorbid opportunistic infections: a case report. ( Ichimori, T; Ishikawa, Y; Nagano, S; Oki, Y; Uchida, K; Yamada, T, 2023) |
| "Six prednisolone and six fMSC treatment cats completed the study." | 1.72 | Comparing adipose-derived mesenchymal stem cells with prednisolone for the treatment of feline inflammatory bowel disease. ( Webb, CB; Webb, TL, 2022) |
| "37." | 1.72 | Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study. ( Bhala, N; Brookes, MJ; Conley, TE; Gonzalez, HA; Hicks, LC; Kennedy, NA; Kent, AJ; Lamb, CA; Mehta, SJ; Patel, KV; Saifuddin, A; Sebastian, S; Segal, JP; Subramanian, S; Walker, GJ, 2022) |
| "High rates of varicella screening and immunisation within a PIBD population are possible, resulting in a reduction in hospital admissions for varicella treatment." | 1.56 | A Decade of Varicella Screening Within a Paediatric Inflammatory Bowel Disease Population. ( Al-Hourani, G; Armstrong, L; Barclay, AR; Curtis, L; Delahunty, C; Eccleston, A; Flynn, DM; Garrick, V; Gervais, L; Hansen, R; Harris, RE; Hegde, V; Merrick, V; Russell, RK; Tayler, R, 2020) |
| " Thus, IGFBP-4 may modulate IGF bioavailability in IBD." | 1.51 | The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis. ( Agnholt, J; Frystyk, J; Hjortebjerg, R; Thomsen, KL, 2019) |
| " Hence maximum amount of drug could be released in the colon that may result in reduction in dose and dose frequency as well as side effects of drug as observed with the conventional dosage form of prednisolone." | 1.48 | Eudragit S100 coated microsponges for Colon targeting of prednisolone. ( Hurkat, P; Jain, A; Jain, SK; Kumari, A; Tiwari, A, 2018) |
| "Retrospective review of AILD [autoimmune hepatitis type 1 and 2 (AIH1, AIH2), primary sclerosing cholangitis (PSC) and autoimmune sclerosing cholangitis (ASC)] seen at two pediatric liver units in Malaysia." | 1.42 | Characteristics and outcome of autoimmune liver disease in Asian children. ( Boey, CC; Chong, SY; Khoh, KM; Lee, WS; Lim, CB; Lum, SH; Ng, RT; Pailoor, J; Teo, KM, 2015) |
| "Urea synthesis was quantified by the functional hepatic nitrogen clearance (FHNC), i." | 1.40 | Prednisolone but not infliximab aggravates the upregulated hepatic nitrogen elimination in patients with active inflammatory bowel disease. ( Aagaard, NK; Agnholt, J; Christensen, LA; Dahlerup, JF; Frystyk, J; Grønbæk, H; Thomsen, KL; Vilstrup, H, 2014) |
| "Colitis was induced by administration of 3% DSS in drinking water to mice for 7days followed by 5days of normal drinking water." | 1.39 | Establishment and validation of a new semi-chronic dextran sulfate sodium-induced model of colitis in mice. ( Igaki, K; Sha, T; Tsuchimori, N; Watanabe, T; Yamasaki, M, 2013) |
| "We report this case of classic Sweet's syndrome with uncommon presentation." | 1.36 | Sweet's syndrome with subacute intestinal obstruction. ( Amareswar, A; Rao, GR; Rao, NR; Somayajulu, MV, 2010) |
| "Treatment with prednisolone resulted in an increase in p-gp expression (P=0." | 1.33 | P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies. ( Allenspach, K; Bergman, PJ; Doherr, MG; Gaschen, F; Gröne, A; Sauter, S, 2006) |
| "Intravenous pulse cyclophosphamide may be a safe and effective treatment in patients with severe IBD unresponsive to steroid treatment and merits evaluation in a controlled trial." | 1.32 | Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease. ( Duchmann, R; Fischinger, J; Moser, C; Stallmach, A; Wittig, BM; Zeitz, M, 2003) |
| "Prednisolone was used as the standard drug for comparison." | 1.32 | Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. ( Jagtap, AG; Phadke, AS; Shirke, SS, 2004) |
| " After 25 days in the hospital, treatment with high dosage of methylprednisolone was started for presumed ulcerative colitis." | 1.28 | Fatal cytomegalovirus (CMV) colitis in a patient receiving low dose prednisolone therapy. ( Aukrust, P; Bjørneklett, A; Farstad, IN; Holter, E; Kremer, D; Moum, B, 1991) |
| "Prednisolone absorption was studied in 13 normal subjects, eight patients with ulcerative colitis and 21 patients with Crohn's disease, by measuring plasma levels after a single oral dose." | 1.27 | Prednisolone absorption in inflammatory bowel disease: correlation with anatomical site and extent. ( Lennard-Jones, JE; McIntyre, PB; Nabi, EM; Phongsathorn, V; Rodrigues, CA; Rosen, A; Spiliadis, C; Willoughby, JM, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.60) | 18.7374 |
| 1990's | 14 (18.18) | 18.2507 |
| 2000's | 24 (31.17) | 29.6817 |
| 2010's | 27 (35.06) | 24.3611 |
| 2020's | 10 (12.99) | 2.80 |
| Authors | Studies |
|---|---|
| Ruiz, JF | 2 |
| Radics, G | 1 |
| Windle, H | 2 |
| Serra, HO | 1 |
| Simplício, AL | 1 |
| Kedziora, K | 2 |
| Fallon, PG | 1 |
| Kelleher, DP | 2 |
| Gilmer, JF | 2 |
| Webb, TL | 1 |
| Webb, CB | 1 |
| Saifuddin, A | 1 |
| Kent, AJ | 1 |
| Mehta, SJ | 1 |
| Hicks, LC | 1 |
| Gonzalez, HA | 1 |
| Segal, JP | 1 |
| Brookes, MJ | 1 |
| Subramanian, S | 1 |
| Bhala, N | 1 |
| Conley, TE | 1 |
| Patel, KV | 1 |
| Lamb, CA | 1 |
| Walker, GJ | 1 |
| Kennedy, NA | 1 |
| Sebastian, S | 1 |
| Tange, K | 1 |
| Yagi, S | 1 |
| Takeshita, E | 1 |
| Abe, M | 1 |
| Yamamoto, Y | 1 |
| Tomida, H | 1 |
| Kawamura, T | 1 |
| Hanayama, M | 1 |
| Matsuura, B | 1 |
| Ikeda, Y | 1 |
| Hiasa, Y | 1 |
| Weber, MC | 1 |
| Bauer, J | 1 |
| Buck, A | 1 |
| Clees, Z | 1 |
| Oertel, R | 1 |
| Kasajima, A | 1 |
| Reischl, S | 1 |
| Wilhelm, D | 1 |
| Friess, H | 1 |
| Neumann, PA | 1 |
| Toba, T | 1 |
| Ikegami, R | 1 |
| Nogami, A | 1 |
| Watanabe, N | 1 |
| Fujii, K | 1 |
| Ogawa, Y | 1 |
| Hojo, A | 1 |
| Fujimoto, A | 1 |
| Matsuda, T | 1 |
| Oki, Y | 1 |
| Nagano, S | 1 |
| Ishikawa, Y | 1 |
| Yamada, T | 1 |
| Ichimori, T | 1 |
| Uchida, K | 1 |
| Harris, RE | 1 |
| Curtis, L | 1 |
| Hegde, V | 1 |
| Garrick, V | 1 |
| Gervais, L | 1 |
| Armstrong, L | 1 |
| Delahunty, C | 1 |
| Eccleston, A | 1 |
| Al-Hourani, G | 1 |
| Flynn, DM | 1 |
| Merrick, V | 1 |
| Barclay, AR | 1 |
| Tayler, R | 1 |
| Hansen, R | 1 |
| Russell, RK | 1 |
| Luangsirithanya, P | 1 |
| Treewaree, S | 1 |
| Pongpaibul, A | 1 |
| Pausawasdi, N | 1 |
| Limsrivilai, J | 1 |
| An, YK | 1 |
| Ramspott, JP | 1 |
| Neureiter, D | 1 |
| Emmanuel, K | 1 |
| Jäger, T | 1 |
| Murugan, R | 1 |
| Saravanan, S | 1 |
| Parimelazhagan, T | 1 |
| Tabuchi, R | 1 |
| Anraku, M | 1 |
| Iohara, D | 1 |
| Ishiguro, T | 1 |
| Ifuku, S | 1 |
| Nagae, T | 1 |
| Uekama, K | 1 |
| Okazaki, S | 1 |
| Takeshita, K | 1 |
| Otagiri, M | 1 |
| Hirayama, F | 1 |
| Classen, J | 1 |
| Dengler, B | 1 |
| Klinger, CJ | 1 |
| Bettenay, SV | 1 |
| Rickerts, V | 1 |
| Mueller, RS | 1 |
| Horai, Y | 1 |
| Kurushima, S | 1 |
| Igawa, T | 1 |
| Ichinose, K | 1 |
| Nakamura, H | 1 |
| Kawakami, A | 1 |
| Kumari, A | 1 |
| Jain, A | 1 |
| Hurkat, P | 1 |
| Tiwari, A | 1 |
| Jain, SK | 1 |
| Lauritzen, D | 1 |
| Andreassen, BU | 1 |
| Heegaard, NHH | 1 |
| Klinge, LG | 1 |
| Walsted, AM | 1 |
| Neland, M | 1 |
| Nielsen, RG | 1 |
| Wittenhagen, P | 1 |
| Ou, R | 1 |
| Shen, Y | 1 |
| Zeng, Y | 1 |
| Zou, L | 1 |
| Jiang, N | 1 |
| Xu, M | 1 |
| Hjortebjerg, R | 1 |
| Thomsen, KL | 2 |
| Agnholt, J | 2 |
| Frystyk, J | 3 |
| Schlanser, JR | 1 |
| Harrison, TM | 1 |
| Wise, A | 1 |
| Kiupel, M | 1 |
| Grønbæk, H | 1 |
| Dahlerup, JF | 2 |
| Aagaard, NK | 1 |
| Christensen, LA | 1 |
| Vilstrup, H | 2 |
| Wu, X | 1 |
| Gao, H | 1 |
| Bleday, R | 1 |
| Zhu, Z | 1 |
| Lee, WS | 1 |
| Lum, SH | 1 |
| Lim, CB | 1 |
| Chong, SY | 1 |
| Khoh, KM | 1 |
| Ng, RT | 1 |
| Teo, KM | 1 |
| Boey, CC | 1 |
| Pailoor, J | 1 |
| Wu, YH | 1 |
| Chang, JY | 1 |
| Chen, HM | 1 |
| Wang, YP | 1 |
| Quaglio, AE | 1 |
| Castilho, AC | 1 |
| Di Stasi, LC | 1 |
| Sankararaman, S | 1 |
| Bobonich, M | 1 |
| Aktay, AN | 1 |
| Travis, S | 1 |
| Kamata, N | 1 |
| Oshitani, N | 1 |
| Sogawa, M | 1 |
| Yamagami, H | 1 |
| Watanabe, K | 1 |
| Fujiwara, Y | 1 |
| Arakawa, T | 1 |
| Soltész, S | 2 |
| Mencke, T | 2 |
| Stunz, M | 1 |
| Diefenbach, C | 2 |
| Ziegeler, S | 1 |
| Molter, GP | 2 |
| Schmidt, S | 1 |
| Mellström, D | 1 |
| Norjavaara, E | 1 |
| Sundh, SV | 1 |
| Saalman, R | 1 |
| Kriel, MH | 1 |
| Tobias, JH | 2 |
| Creed, TJ | 1 |
| Lockett, M | 1 |
| Linehan, J | 1 |
| Bell, A | 1 |
| Przemioslo, R | 1 |
| Smithson, JE | 1 |
| Brooklyn, TN | 1 |
| Fraser, WD | 2 |
| Probert, CS | 2 |
| Avinash, B | 1 |
| Dutta, AK | 1 |
| Chacko, A | 1 |
| Raithel, M | 1 |
| Nägel, A | 1 |
| Zopf, Y | 1 |
| deRossi, T | 1 |
| Stengel, Ch | 1 |
| Hagel, A | 1 |
| Kressel, J | 1 |
| Hahn, EG | 1 |
| Konturek, P | 1 |
| Fleming, A | 1 |
| Jankowski, J | 1 |
| Goldsmith, P | 2 |
| Rintamäki, H | 1 |
| Salo, HM | 1 |
| Vaarala, O | 1 |
| Kolho, KL | 2 |
| Kriel, M | 1 |
| Sayers, A | 1 |
| Williams, AM | 1 |
| Koch, A | 1 |
| Zacharowski, K | 1 |
| Somayajulu, MV | 1 |
| Rao, GR | 1 |
| Amareswar, A | 1 |
| Rao, NR | 1 |
| Jagtap, AG | 2 |
| Niphadkar, PV | 1 |
| Phadke, AS | 2 |
| Thachil, J | 1 |
| Wenzl, HH | 1 |
| Sha, T | 1 |
| Igaki, K | 1 |
| Yamasaki, M | 1 |
| Watanabe, T | 1 |
| Tsuchimori, N | 1 |
| Pietra, M | 1 |
| Fracassi, F | 1 |
| Diana, A | 1 |
| Gazzotti, T | 1 |
| Bettini, G | 1 |
| Peli, A | 1 |
| Morini, M | 1 |
| Pagliuca, G | 1 |
| Roncada, P | 1 |
| Kostiainen, M | 1 |
| Snellman, E | 1 |
| Vaalasti, A | 1 |
| Rantanen, T | 1 |
| Reunala, T | 1 |
| Ochsenkühn, T | 1 |
| Sackmann, M | 1 |
| Göke, B | 1 |
| Nagy, F | 1 |
| Stallmach, A | 1 |
| Wittig, BM | 1 |
| Moser, C | 1 |
| Fischinger, J | 1 |
| Duchmann, R | 1 |
| Zeitz, M | 1 |
| Sawada, K | 1 |
| Woodruff, TM | 1 |
| Arumugam, TV | 1 |
| Shiels, IA | 1 |
| Reid, RC | 1 |
| Fairlie, DP | 1 |
| Taylor, SM | 1 |
| Shirke, SS | 1 |
| Meyer, AM | 1 |
| Ramzan, NN | 1 |
| Loftus, EV | 1 |
| Heigh, RI | 1 |
| Leighton, JA | 1 |
| Hanauer, SB | 1 |
| Sparrow, M | 1 |
| Ikenoue, Y | 1 |
| Tagami, T | 1 |
| Murata, M | 1 |
| Allenspach, K | 1 |
| Bergman, PJ | 1 |
| Sauter, S | 1 |
| Gröne, A | 1 |
| Doherr, MG | 1 |
| Gaschen, F | 1 |
| Mey, C | 1 |
| Röhrig, S | 1 |
| Vihinen, MK | 1 |
| Raivio, T | 1 |
| Verkasalo, M | 1 |
| Jänne, OA | 1 |
| Newton, M | 1 |
| Cooper, BT | 1 |
| Aasakura, H | 1 |
| Honma, T | 1 |
| Sugimura, K | 1 |
| Actis, GC | 1 |
| Ottobrelli, A | 1 |
| Lavezzo, B | 1 |
| Modena, V | 1 |
| Regge, D | 1 |
| Veltri, A | 1 |
| Tomasini, C | 1 |
| Puiatti, P | 1 |
| Novero, D | 1 |
| Verme, G | 1 |
| Kjeldsen, J | 1 |
| Lauritsen, K | 1 |
| De Muckadell, OB | 1 |
| Robinson, RJ | 1 |
| Iqbal, SJ | 1 |
| Wolfe, R | 1 |
| Patel, K | 1 |
| Abrams, K | 1 |
| Mayberry, JF | 1 |
| Ardite, E | 1 |
| Panés, J | 1 |
| Miranda, M | 1 |
| Salas, A | 1 |
| Elizalde, JI | 1 |
| Sans, M | 1 |
| Arce, Y | 1 |
| Bordas, JM | 1 |
| Fernández-Checa, JC | 1 |
| Piqué, JM | 1 |
| Kim, YS | 1 |
| Son, M | 1 |
| Ko, JI | 1 |
| Cho, H | 1 |
| Yoo, M | 1 |
| Kim, WB | 1 |
| Song, IS | 1 |
| Kim, CY | 1 |
| Takada, K | 1 |
| Gomollón, F | 1 |
| Hinojosa, J | 1 |
| Nos, P | 1 |
| Fellermann, K | 1 |
| Herrlinger, KR | 1 |
| Witthoeft, T | 1 |
| Homann, N | 1 |
| Ludwig, D | 1 |
| Stange, EF | 1 |
| Gustafsson, B | 1 |
| Miller-Larsson, A | 1 |
| Persson, CG | 1 |
| Willard, MD | 1 |
| Grønbek, H | 1 |
| Thøgersen, T | 1 |
| Flyvbjerg, A | 1 |
| Campieri, M | 1 |
| Straub, RH | 1 |
| Herfarth, H | 1 |
| Falk, W | 1 |
| Andus, T | 1 |
| Schölmerich, J | 1 |
| Kubota, Y | 1 |
| Sawada, T | 1 |
| Muto, T | 1 |
| Aukrust, P | 1 |
| Moum, B | 1 |
| Farstad, IN | 1 |
| Holter, E | 1 |
| Bjørneklett, A | 1 |
| Kremer, D | 1 |
| McGarity, B | 1 |
| Walls, AF | 1 |
| Church, MK | 1 |
| Millward-Sadler, GH | 1 |
| Robertson, DA | 1 |
| Banerjee, AK | 1 |
| Peters, TJ | 1 |
| Hawkey, CJ | 1 |
| Rodrigues, CA | 1 |
| Nabi, EM | 1 |
| Spiliadis, C | 1 |
| McIntyre, PB | 1 |
| Phongsathorn, V | 1 |
| Lennard-Jones, JE | 1 |
| Rosen, A | 1 |
| Willoughby, JM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Prednisolone and Infliximab on the Regulation of Urea Synthesis in Patients With Active Ulcerative Colitis and Crohn's Disease[NCT00955123] | 40 participants (Actual) | Observational | 2009-01-31 | Completed | |||
| Bone Density in Children With IBD Treated With Amorphous Calcium or Commercial Crystalline Calcium: A Prospective Randomized Multicenter Trial[NCT02470663] | 0 participants (Actual) | Interventional | 2015-07-31 | Withdrawn (stopped due to company and Sheba did not reach an agreement) | |||
| Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease[NCT04508088] | 92 participants (Anticipated) | Observational | 2020-09-10 | Recruiting | |||
| Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease[NCT00152620] | 40 participants | Interventional | 2004-06-30 | Terminated (stopped due to study completed) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for prednisolone and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Diarrhea in chronic inflammatory bowel diseases.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antidiarrheals; Bacterial Infections | 2012 |
[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Bude | 2003 |
[Conservative therapy of inflammatory bowel diseases].
Topics: Acute Disease; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chro | 2002 |
Leukocytapheresis as an adjunct to conventional medication for inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Combined Modality Therapy; Humans; Inflammatory Bowel Diseases; Leukaphere | 2003 |
COLAL-PRED Alizyme.
Topics: Animals; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Inflammato | 2004 |
[Emergency drug therapy of non-specific inflammatory bowel diseases--progress on diagnosis and therapy].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Drug Combin | 1995 |
[DDS preparations of drugs for inflammatory bowel disease].
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Capsules; De | 1999 |
[Budesonide and inflammatory bowel disease].
Topics: Anti-Inflammatory Agents; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; | 1999 |
Feline inflammatory bowel disease: a review.
Topics: Animals; Cat Diseases; Cats; Diet; Inflammatory Bowel Diseases; Metronidazole; Prednisolone | 1999 |
New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.
Topics: Acute Disease; Aspirin; Beclomethasone; Budesonide; Colitis, Ulcerative; Crohn Disease; Drug Therapy | 2002 |
Acute treatment of inflammatory bowel disease, prednisolone: dosage and duration.
Topics: Humans; Inflammatory Bowel Diseases; Prednisolone | 1989 |
9 trials available for prednisolone and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease.
Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Drug Administration S | 2010 |
Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD).
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Diseas | 2010 |
Plasma concentrations and therapeutic effects of budesonide in dogs with inflammatory bowel disease.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Budesonide; Chromatography, Liquid; Dog Dis | 2013 |
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease.
Topics: Animals; Antibodies, Monoclonal; Body Weight; Colon; Disease Models, Animal; Eating; Edema; Humans; | 2003 |
Circulating glucocorticoid bioactivity during peroral glucocorticoid treatment in children and adolescents with inflammatory bowel disease.
Topics: Adolescent; Age Factors; Budesonide; Child; Child, Preschool; Dose-Response Relationship, Drug; Fema | 2008 |
Serum concentrations of orosomucoid: improved decision-making for tapering prednisolone therapy in patients with active inflammatory bowel disease?
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Decision Making; Female; Humans; Inflammatory Bowel Dis | 1997 |
The effect of rectally administered steroids on bone turnover: a comparative study.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Alkaline Phosphatase; Amino Acids; Anti-Inflammator | 1998 |
Tacrolimus: a new immunosuppressant for steroid refractory inflammatory bowel disease.
Topics: Dose-Response Relationship, Drug; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bo | 2001 |
Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment.
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Dose-Response Relationship, Drug; Endopeptidases; | 2002 |
57 other studies available for prednisolone and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Design, synthesis, and pharmacological effects of a cyclization-activated steroid prodrug for colon targeting in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Animals; Bacteria; Colon; Cyclization; Drug Carriers; Drug Delivery Systems | 2009 |
Comparing adipose-derived mesenchymal stem cells with prednisolone for the treatment of feline inflammatory bowel disease.
Topics: Animals; Body Weight; Cat Diseases; Cats; Chronic Disease; Female; Inflammatory Bowel Diseases; Male | 2022 |
Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID-19 pandemic: the PREPARE-IBD multicentre cohort study.
Topics: Adrenal Cortex Hormones; Cohort Studies; Colitis, Ulcerative; COVID-19; Crohn Disease; Humans; Infla | 2022 |
Oral administration of human carbonic anhydrase I suppresses colitis in a murine inflammatory bowel disease model.
Topics: Administration, Oral; Animals; Carbonic Anhydrase I; Colitis; Disease Models, Animal; Humans; Inflam | 2022 |
Perioperative Low-Dose Prednisolone Treatment Has Beneficial Effects on Postoperative Recovery and Anastomotic Healing in a Murine Colitis Model.
Topics: Anastomosis, Surgical; Anastomotic Leak; Animals; Colitis; Inflammatory Bowel Diseases; Mice; Predni | 2023 |
Multiple ulcerative colitis-associated aseptic abscesses successfully treated with infliximab: a case report.
Topics: Abscess; Aged; Colitis, Ulcerative; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Prednis | 2023 |
Ulcerative colitis successfully treated with vedolizumab in the presence of comorbid opportunistic infections: a case report.
Topics: Colitis, Ulcerative; Cytomegalovirus Infections; Fluconazole; Humans; Inflammatory Bowel Diseases; M | 2023 |
A Decade of Varicella Screening Within a Paediatric Inflammatory Bowel Disease Population.
Topics: Anti-Inflammatory Agents; Antibodies, Viral; Chickenpox; Child; Female; Hospitalization; Humans; Imm | 2020 |
Cytomegalovirus enterocolitis with subsequent diagnosis of coexisting new-onset inflammatory bowel disease: Two case reports and review of the literature.
Topics: Azathioprine; Cytomegalovirus Infections; Delayed Diagnosis; Female; Glucocorticoids; Humans; Immuno | 2021 |
Common mistakes with steroids.
Topics: Administration, Oral; Adrenal Cortex Hormones; Biomarkers; Budesonide; C-Reactive Protein; Feces; Hu | 2021 |
Granulomatosis with polyangiitis presents with skip lesions of the bowel.
Topics: Abdominal Pain; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Granulomatosis wit | 2021 |
Study of intestinal anti-inflammatory activity of Phoenix loureiroi Kunth (Arecaceae) fruit.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arecaceae; Colitis; Fruit; India; Inflammatory Bowe | 2017 |
Surface-deacetylated chitin nanofibers reinforced with a sulfobutyl ether β-cyclodextrin gel loaded with prednisolone as potential therapy for inflammatory bowel disease.
Topics: Animals; beta-Cyclodextrins; Chitin; Colitis; Delayed-Action Preparations; Dextran Sulfate; Gels; In | 2017 |
Cutaneous alternariosis in an immunocompromised dog successfully treated with cold plasma and cessation of immunosuppressive medication.
Topics: Alternariosis; Animals; Anti-Inflammatory Agents; Antifungal Agents; Cyclosporine; Dog Diseases; Dog | 2017 |
[Coexistence of Takayasu's arteritis and inflammatory colitis detected by fluorodeoxyglucose positron emission tomography].
Topics: Adult; Colitis; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inflammatory Bowel D | 2017 |
Eudragit S100 coated microsponges for Colon targeting of prednisolone.
Topics: Colon; Drug Delivery Systems; Drug Liberation; Inflammatory Bowel Diseases; Polymethacrylic Acids; P | 2018 |
Pediatric Inflammatory Bowel Diseases: Should We Be Looking for Kidney Abnormalities?
Topics: Adolescent; Body Mass Index; Child; Child, Preschool; Cohort Studies; Cross-Sectional Studies; Femal | 2018 |
[Effects of Pim-1 inhibitor on mouse model of inflammatory bowel disease induced by TNBS].
Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Colitis; Colon; Ethanol; Forkhead Transcrip | 2018 |
The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis.
Topics: Adult; Biological Availability; Female; Glycoproteins; Humans; Immunosuppression Therapy; Induction | 2019 |
DIFFERENTIATING ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA TYPE 2 FROM INFLAMMATORY BOWEL DISEASE IN A SNOW LEOPARD (
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Chlorambucil; Enteropat | 2019 |
Prednisolone but not infliximab aggravates the upregulated hepatic nitrogen elimination in patients with active inflammatory bowel disease.
Topics: Adult; Antibodies, Monoclonal; Female; Follow-Up Studies; Gastrointestinal Agents; Glucocorticoids; | 2014 |
Homeobox transcription factor VentX regulates differentiation and maturation of human dendritic cells.
Topics: Adult; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cells, Cultured; De | 2014 |
Characteristics and outcome of autoimmune liver disease in Asian children.
Topics: Adolescent; Anti-Inflammatory Agents; Asian People; Azathioprine; Child; Child, Preschool; Cholangit | 2015 |
Pyostomatitis vegetans: An oral manifestation of inflammatory bowel disease.
Topics: Adult; Colchicine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Inflammatory Bowel | 2015 |
Experimental evidence of heparanase, Hsp70 and NF-κB gene expression on the response of anti-inflammatory drugs in TNBS-induced colonic inflammation.
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Colitis; Colon; Cytokines; Gene Express | 2015 |
Alopecia Areata in an Adolescent With Inflammatory Bowel Disease.
Topics: Adolescent; Alopecia Areata; Child; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infla | 2017 |
How do you avoid and treat steroid side effects?
Topics: Adrenal Cortex Hormones; Biological Availability; Glucocorticoids; Humans; Inflammatory Bowel Diseas | 2008 |
Usefulness of magnetic resonance imaging for detection of asymptomatic osteonecrosis of the femoral head in patients with inflammatory bowel disease on long-term corticosteroid treatment.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Femur Head Necrosis; Follow-Up St | 2008 |
Attenuation of a rocuronium-induced neuromuscular block in patients receiving prednisolone.
Topics: Adolescent; Adult; Androstanols; Drug Interactions; Female; Humans; Inflammatory Bowel Diseases; Mal | 2009 |
Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden.
Topics: Absorptiometry, Photon; Adolescent; Anti-Inflammatory Agents; Azathioprine; Body Mass Index; Bone De | 2009 |
Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden.
Topics: Absorptiometry, Photon; Adolescent; Anti-Inflammatory Agents; Azathioprine; Body Mass Index; Bone De | 2009 |
Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden.
Topics: Absorptiometry, Photon; Adolescent; Anti-Inflammatory Agents; Azathioprine; Body Mass Index; Bone De | 2009 |
Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from Western Sweden.
Topics: Absorptiometry, Photon; Adolescent; Anti-Inflammatory Agents; Azathioprine; Body Mass Index; Bone De | 2009 |
Pediatric inflammatory bowel disease in South India.
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Agents; Azathioprine; Budesonide; Catchment Are | 2009 |
In vivo analysis of gut function and disease changes in a zebrafish larvae model of inflammatory bowel disease: a feasibility study.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; | 2010 |
New means to monitor the effect of glucocorticoid therapy in children.
Topics: Adolescent; Adult; Biological Assay; Blood Sedimentation; C-Reactive Protein; Cells, Cultured; Child | 2010 |
IL-6 may modulate the skeletal response to glucocorticoids during exacerbations of inflammatory bowel disease.
Topics: Adult; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Cell Proliferation; Collagen Type | 2010 |
Sweet's syndrome with subacute intestinal obstruction.
Topics: Anti-Infective Agents; Biopsy; C-Reactive Protein; Female; Humans; Inflammatory Bowel Diseases; Inte | 2010 |
Investigation into drug release from colon-specific azoreductase-activated steroid prodrugs using in-vitro models.
Topics: Amino Acids; Animals; Colon; Drug Delivery Systems; Humans; Hydrogen-Ion Concentration; Inflammatory | 2011 |
Protective effect of aqueous extract of Bombax malabaricum DC on experimental models of inflammatory bowel disease in rats and mice.
Topics: Acetic Acid; Animals; Bombax; Colitis; Disease Models, Animal; Female; India; Indomethacin; Inflamma | 2011 |
Thrombosis with inflammatory bowel disease--bleed, clot or break.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Hematoma; Hematuria; Heparin, Low-Mo | 2012 |
Establishment and validation of a new semi-chronic dextran sulfate sodium-induced model of colitis in mice.
Topics: Animals; Anti-Inflammatory Agents; Antibodies; Colitis; Cytokines; Dextran Sulfate; Disease Models, | 2013 |
[Pyoderma gangrenosum--a less well known ulcerous skin disease].
Topics: Adult; Antibodies, Monoclonal; Dermatologic Agents; Female; Glucocorticoids; Humans; Inflammatory Bo | 2002 |
Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Crohn Disease; Cyclophosphamide; Drug Resistance; Fe | 2003 |
Effect of polyherbal formulation on experimental models of inflammatory bowel diseases.
Topics: Animals; Chemistry, Pharmaceutical; Disease Models, Animal; Female; Inflammatory Bowel Diseases; Int | 2004 |
The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Campylobacter jejuni; Clost | 2004 |
Development and validation of a novel IL-10 deficient cell transfer model for colitis.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Cell Transplantation; Disease Models, Anim | 2005 |
P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies.
Topics: Adrenal Cortex Hormones; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biopsy; D | 2006 |
Influence of a continuous prednisolone medication on the time course of neuromuscular block of atracurium in patients with chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Anesthesia Recovery Period; Atracurium; Dose-Response Relationship, Drug; D | 2008 |
Benign intracranial hypertension during prednisolone treatment for inflammatory bowel disease.
Topics: Adult; Colitis, Ulcerative; Crohn Disease; Female; Headache; Humans; Inflammatory Bowel Diseases; Pa | 1994 |
Recurrent necroinflammatory disease of multiple organs and colon. Systemic presentation of inflammatory bowel disease or gut involvement during systemic disorder.
Topics: Adult; Anti-Inflammatory Agents; Humans; Inflammatory Bowel Diseases; Lymph Nodes; Male; Panniculiti | 1996 |
Effects of steroid treatment on activation of nuclear factor kappaB in patients with inflammatory bowel disease.
Topics: Adult; Anti-Inflammatory Agents; Electrophoresis, Polyacrylamide Gel; Humans; Inflammatory Bowel Dis | 1998 |
Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease.
Topics: Acetic Acid; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents; Anti-Inflammatory Age | 1999 |
Topical and oral anti-inflammatory activity of budesonide compared with oral prednisolone in an animal model using allergen-induced gut mucosal exudation of plasma as a marker.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Inflammatory Agents; Budesonide; Diseas | 2001 |
Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Inf | 2002 |
[Controversy--surgical vs. medical management of inflammatory bowel disease].
Topics: Adolescent; Adult; Child; Colectomy; Female; Humans; Ileostomy; Inflammatory Bowel Diseases; Male; M | 1992 |
Fatal cytomegalovirus (CMV) colitis in a patient receiving low dose prednisolone therapy.
Topics: Arthritis; Colitis; Colon; Cytomegalovirus; Cytomegalovirus Infections; Diagnosis, Differential; Fem | 1991 |
Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Cell Count; Colonoscopy; Humans; Inflammatory Bowel | 1990 |
Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.
Topics: Animals; Cell Membrane Permeability; Chromium Radioisotopes; Disease Models, Animal; Edetic Acid; Il | 1990 |
Prednisolone absorption in inflammatory bowel disease: correlation with anatomical site and extent.
Topics: Adolescent; Adult; Aged; Colitis, Ulcerative; Crohn Disease; Female; Humans; Inflammatory Bowel Dise | 1987 |